{
  "paper_id": "PMC11381393",
  "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11381393/",
  "figures": {
    "figure_1": {
      "figure_number": "Figure 1",
      "title": "Figure 1.",
      "caption": "Annual publication volume and publication trend in the field of breast cancer organoid research in the WOS core collection.",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb9d/11381393/1c33f81f71fd/fimmu-15-1413858-g001.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb9d/11381393/1c33f81f71fd/fimmu-15-1413858-g001.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb9d/11381393/1c33f81f71fd/fimmu-15-1413858-g001.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb9d/11381393/1c33f81f71fd/fimmu-15-1413858-g001.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "f1",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb9d/11381393/1c33f81f71fd/fimmu-15-1413858-g001.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC11381393/images/figure_1.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb9d/11381393/1c33f81f71fd/fimmu-15-1413858-g001.jpg"
    },
    "figure_2": {
      "figure_number": "Figure 2",
      "title": "Figure 2.",
      "caption": "Countries’ collaboration world map in the WOS core collection about breast cancer organoid research. The red lines represents cooperation between countries.",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb9d/11381393/8e6a5350f82b/fimmu-15-1413858-g002.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb9d/11381393/8e6a5350f82b/fimmu-15-1413858-g002.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb9d/11381393/8e6a5350f82b/fimmu-15-1413858-g002.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb9d/11381393/8e6a5350f82b/fimmu-15-1413858-g002.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "f2",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb9d/11381393/8e6a5350f82b/fimmu-15-1413858-g002.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC11381393/images/figure_2.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb9d/11381393/8e6a5350f82b/fimmu-15-1413858-g002.jpg"
    },
    "figure_3": {
      "figure_number": "Figure 3",
      "title": "Figure 3.",
      "caption": "WOS core collection’s keywords’ clusters in breast cancer organoid research. Each cluster can to a certain extent reflect a focal area of interest within the field, and be ranked based on the level of attention in related research.",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb9d/11381393/181f97018d81/fimmu-15-1413858-g003.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb9d/11381393/181f97018d81/fimmu-15-1413858-g003.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb9d/11381393/181f97018d81/fimmu-15-1413858-g003.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb9d/11381393/181f97018d81/fimmu-15-1413858-g003.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "f3",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb9d/11381393/181f97018d81/fimmu-15-1413858-g003.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC11381393/images/figure_3.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb9d/11381393/181f97018d81/fimmu-15-1413858-g003.jpg"
    },
    "figure_4": {
      "figure_number": "Figure 4",
      "title": "Figure 4.",
      "caption": "WOS core collection’s hotspots in breast cancer organoid research.",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb9d/11381393/154fc05a81ac/fimmu-15-1413858-g004.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb9d/11381393/154fc05a81ac/fimmu-15-1413858-g004.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb9d/11381393/154fc05a81ac/fimmu-15-1413858-g004.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb9d/11381393/154fc05a81ac/fimmu-15-1413858-g004.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "f4",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb9d/11381393/154fc05a81ac/fimmu-15-1413858-g004.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC11381393/images/figure_4.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb9d/11381393/154fc05a81ac/fimmu-15-1413858-g004.jpg"
    },
    "figure_5": {
      "figure_number": "Figure 5",
      "title": "Figure 5.",
      "caption": "Timeline of breast cancer organoid culture progress. From left to right, the timeline depicts five different years and progress in culturing breast cancer organoids. Bissell and colleagues pioneered the 3D culturing technique in the 1980s. In 2013, Drose and associates cultivated the first patient-derived breast cancer organoid. In 2015, Zubeldia-Plazaola and colleagues discovered that slow digestion at low enzyme concentrations significantly enhanced the success rate of organoid culturing. In 2016, Zhang and co-workers successfully constructed a breast organoid. In 2018, Sachs and associates discovered the effect of neuregulin-1 and Wnt-3A on organoid growth, further developing organoid technology.",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb9d/11381393/7e60e7c2f4a4/fimmu-15-1413858-g005.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb9d/11381393/7e60e7c2f4a4/fimmu-15-1413858-g005.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb9d/11381393/7e60e7c2f4a4/fimmu-15-1413858-g005.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb9d/11381393/7e60e7c2f4a4/fimmu-15-1413858-g005.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "f5",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb9d/11381393/7e60e7c2f4a4/fimmu-15-1413858-g005.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC11381393/images/figure_5.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb9d/11381393/7e60e7c2f4a4/fimmu-15-1413858-g005.jpg"
    },
    "figure_6": {
      "figure_number": "Figure 6",
      "title": "Figure 6.",
      "caption": "Application of breast cancer organoids. The current applications of breast cancer-like organs involve four main areas. The first is drug screening, where patient-derived breast cancer cells are cultured into organoids that then undergo in vitro drug screening, allowing for targeted therapy. The second area is the establishment of breast cancer organoid biobanks. In the third and fourth areas, organoid-level research on tumor mechanisms and gene editing can be conducted.",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb9d/11381393/45dbb513ddb1/fimmu-15-1413858-g006.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb9d/11381393/45dbb513ddb1/fimmu-15-1413858-g006.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb9d/11381393/45dbb513ddb1/fimmu-15-1413858-g006.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb9d/11381393/45dbb513ddb1/fimmu-15-1413858-g006.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "f6",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb9d/11381393/45dbb513ddb1/fimmu-15-1413858-g006.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC11381393/images/figure_6.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb9d/11381393/45dbb513ddb1/fimmu-15-1413858-g006.jpg"
    }
  },
  "claims": [
    {
      "sentence": "Figure 1\n depicts the total number of papers published each year, with an increasing trend from six articles in 2003 to 156 articles in 2021.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "The USA had the most extensive collaborations with other countries and regions, including Europe, China, and Japan (\nFigure 2\n).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The top nine keyword groups from the analysis were “breast cancer organoid”, “therapeutic response”, “catalytic domain”, “progesterone receptor”, “triple-negative breast cancer”, “specific llama-derived antibodies”, “signaling mediate”, and “mesenchymal stromal cell” (\nFigure 3\n).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Figure 4\n demonstrates that researchers recently focused on “survival” (2022–2024), “3D culture” (2018–2022), “mouse model” (2019–2018), “stem cells” (2016–2020), and “morphogenesis” (2014–2020).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Each cluster can to a certain extent reflect a focal area of interest within the field, and be ranked based on the level of attention in related research.Figure 4.",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "In the 1980s, Bissell and others pioneered the three-dimensional(3D) culturing technique in the process of studying breast cancer, elucidating the influence of the extracellular matrix on gene expression (\nFigure 5\n).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "In 2013, Drose and colleagues extracted tumors from patients using surgical methods, enzymatically treated tumor fragments with collagenase and hyaluronidase, and cultivated the first patient-derived breast cancer organoid (27) (\nFigure 5\n).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "In 2015, Zubeldia-Plazaola and team used 3D cell culture technology to establish primary mammary epithelial cell lines more effectively, discovering that slow digestion at low enzyme concentrations could significantly enhance the success rate of organoid culturing (28) (\nFigure 5\n).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "In 2016, Zhang et al. first placed breast cells from individual mice Lgr5+ in an intestinal organoid culture medium and added growth factors like epidermal growth factor(EGF), exogenous ligands Wnt-3A of the Wnt signaling pathway, and R-spondin (\nFigure 5\n).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "In 2018, Sachs and others published a paper in “Cell”, where they collected samples from over 150 breast cancer patients, successfully producing over 100 organoids (\nFigure 5\n).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "Comparison of other breast cancer research models with organoid technology\nThe bibliometric analysis (\nFigure 4\n) identified the recent high-citation keywords in breast cancer organoids: “3D culture”, “mouse model”, and “morphogenesis mouse”.",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Additionally, “catalytic domain”, “progesterone receptor”, “triple-negative breast cancer”, “specific llama-derived antibodies”, “signaling mediate”, and “mesenchymal stromal cell” (\nFigure 3\n) demonstrated the mechanistic applications of breast cancer-like organs.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Figure 6\n summarizes the current four most important areas of application for breast cancer organoids.",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "Figure 1\n depicts the total number of papers published each year, with an increasing trend from six articles in 2003 to 156 articles in 2021.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "The USA had the most extensive collaborations with other countries and regions, including Europe, China, and Japan (\nFigure 2\n).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The top nine keyword groups from the analysis were “breast cancer organoid”, “therapeutic response”, “catalytic domain”, “progesterone receptor”, “triple-negative breast cancer”, “specific llama-derived antibodies”, “signaling mediate”, and “mesenchymal stromal cell” (\nFigure 3\n).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Figure 4\n demonstrates that researchers recently focused on “survival” (2022–2024), “3D culture” (2018–2022), “mouse model” (2019–2018), “stem cells” (2016–2020), and “morphogenesis” (2014–2020).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Each cluster can to a certain extent reflect a focal area of interest within the field, and be ranked based on the level of attention in related research.Figure 4.",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "In the 1980s, Bissell and others pioneered the three-dimensional(3D) culturing technique in the process of studying breast cancer, elucidating the influence of the extracellular matrix on gene expression (\nFigure 5\n).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "In 2013, Drose and colleagues extracted tumors from patients using surgical methods, enzymatically treated tumor fragments with collagenase and hyaluronidase, and cultivated the first patient-derived breast cancer organoid (27) (\nFigure 5\n).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "In 2015, Zubeldia-Plazaola and team used 3D cell culture technology to establish primary mammary epithelial cell lines more effectively, discovering that slow digestion at low enzyme concentrations could significantly enhance the success rate of organoid culturing (28) (\nFigure 5\n).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "In 2016, Zhang et al. first placed breast cells from individual mice Lgr5+ in an intestinal organoid culture medium and added growth factors like epidermal growth factor(EGF), exogenous ligands Wnt-3A of the Wnt signaling pathway, and R-spondin (\nFigure 5\n).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "In 2018, Sachs and others published a paper in “Cell”, where they collected samples from over 150 breast cancer patients, successfully producing over 100 organoids (\nFigure 5\n).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "Comparison of other breast cancer research models with organoid technology\nThe bibliometric analysis (\nFigure 4\n) identified the recent high-citation keywords in breast cancer organoids: “3D culture”, “mouse model”, and “morphogenesis mouse”.",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Additionally, “catalytic domain”, “progesterone receptor”, “triple-negative breast cancer”, “specific llama-derived antibodies”, “signaling mediate”, and “mesenchymal stromal cell” (\nFigure 3\n) demonstrated the mechanistic applications of breast cancer-like organs.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Figure 6\n summarizes the current four most important areas of application for breast cancer organoids.",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "Figure 1\n depicts the total number of papers published each year, with an increasing trend from six articles in 2003 to 156 articles in 2021.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "The USA had the most extensive collaborations with other countries and regions, including Europe, China, and Japan (\nFigure 2\n).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The top nine keyword groups from the analysis were “breast cancer organoid”, “therapeutic response”, “catalytic domain”, “progesterone receptor”, “triple-negative breast cancer”, “specific llama-derived antibodies”, “signaling mediate”, and “mesenchymal stromal cell” (\nFigure 3\n).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Figure 4\n demonstrates that researchers recently focused on “survival” (2022–2024), “3D culture” (2018–2022), “mouse model” (2019–2018), “stem cells” (2016–2020), and “morphogenesis” (2014–2020).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Each cluster can to a certain extent reflect a focal area of interest within the field, and be ranked based on the level of attention in related research.Figure 4.",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "In the 1980s, Bissell and others pioneered the three-dimensional(3D) culturing technique in the process of studying breast cancer, elucidating the influence of the extracellular matrix on gene expression (\nFigure 5\n).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "In 2013, Drose and colleagues extracted tumors from patients using surgical methods, enzymatically treated tumor fragments with collagenase and hyaluronidase, and cultivated the first patient-derived breast cancer organoid (27) (\nFigure 5\n).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "In 2015, Zubeldia-Plazaola and team used 3D cell culture technology to establish primary mammary epithelial cell lines more effectively, discovering that slow digestion at low enzyme concentrations could significantly enhance the success rate of organoid culturing (28) (\nFigure 5\n).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "In 2016, Zhang et al. first placed breast cells from individual mice Lgr5+ in an intestinal organoid culture medium and added growth factors like epidermal growth factor(EGF), exogenous ligands Wnt-3A of the Wnt signaling pathway, and R-spondin (\nFigure 5\n).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "In 2018, Sachs and others published a paper in “Cell”, where they collected samples from over 150 breast cancer patients, successfully producing over 100 organoids (\nFigure 5\n).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "Comparison of other breast cancer research models with organoid technology\nThe bibliometric analysis (\nFigure 4\n) identified the recent high-citation keywords in breast cancer organoids: “3D culture”, “mouse model”, and “morphogenesis mouse”.",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Additionally, “catalytic domain”, “progesterone receptor”, “triple-negative breast cancer”, “specific llama-derived antibodies”, “signaling mediate”, and “mesenchymal stromal cell” (\nFigure 3\n) demonstrated the mechanistic applications of breast cancer-like organs.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Figure 6\n summarizes the current four most important areas of application for breast cancer organoids.",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "Figure 1\n depicts the total number of papers published each year, with an increasing trend from six articles in 2003 to 156 articles in 2021.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "The USA had the most extensive collaborations with other countries and regions, including Europe, China, and Japan (\nFigure 2\n).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The top nine keyword groups from the analysis were “breast cancer organoid”, “therapeutic response”, “catalytic domain”, “progesterone receptor”, “triple-negative breast cancer”, “specific llama-derived antibodies”, “signaling mediate”, and “mesenchymal stromal cell” (\nFigure 3\n).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Figure 4\n demonstrates that researchers recently focused on “survival” (2022–2024), “3D culture” (2018–2022), “mouse model” (2019–2018), “stem cells” (2016–2020), and “morphogenesis” (2014–2020).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Each cluster can to a certain extent reflect a focal area of interest within the field, and be ranked based on the level of attention in related research.Figure 4.",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "In the 1980s, Bissell and others pioneered the three-dimensional(3D) culturing technique in the process of studying breast cancer, elucidating the influence of the extracellular matrix on gene expression (\nFigure 5\n).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "In 2013, Drose and colleagues extracted tumors from patients using surgical methods, enzymatically treated tumor fragments with collagenase and hyaluronidase, and cultivated the first patient-derived breast cancer organoid (27) (\nFigure 5\n).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "In 2015, Zubeldia-Plazaola and team used 3D cell culture technology to establish primary mammary epithelial cell lines more effectively, discovering that slow digestion at low enzyme concentrations could significantly enhance the success rate of organoid culturing (28) (\nFigure 5\n).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "In 2016, Zhang et al. first placed breast cells from individual mice Lgr5+ in an intestinal organoid culture medium and added growth factors like epidermal growth factor(EGF), exogenous ligands Wnt-3A of the Wnt signaling pathway, and R-spondin (\nFigure 5\n).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "In 2018, Sachs and others published a paper in “Cell”, where they collected samples from over 150 breast cancer patients, successfully producing over 100 organoids (\nFigure 5\n).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "Comparison of other breast cancer research models with organoid technology\nThe bibliometric analysis (\nFigure 4\n) identified the recent high-citation keywords in breast cancer organoids: “3D culture”, “mouse model”, and “morphogenesis mouse”.",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Additionally, “catalytic domain”, “progesterone receptor”, “triple-negative breast cancer”, “specific llama-derived antibodies”, “signaling mediate”, and “mesenchymal stromal cell” (\nFigure 3\n) demonstrated the mechanistic applications of breast cancer-like organs.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Figure 6\n summarizes the current four most important areas of application for breast cancer organoids.",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "Figure 1\n depicts the total number of papers published each year, with an increasing trend from six articles in 2003 to 156 articles in 2021.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "The USA had the most extensive collaborations with other countries and regions, including Europe, China, and Japan (\nFigure 2\n).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The top nine keyword groups from the analysis were “breast cancer organoid”, “therapeutic response”, “catalytic domain”, “progesterone receptor”, “triple-negative breast cancer”, “specific llama-derived antibodies”, “signaling mediate”, and “mesenchymal stromal cell” (\nFigure 3\n).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Figure 4\n demonstrates that researchers recently focused on “survival” (2022–2024), “3D culture” (2018–2022), “mouse model” (2019–2018), “stem cells” (2016–2020), and “morphogenesis” (2014–2020).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Each cluster can to a certain extent reflect a focal area of interest within the field, and be ranked based on the level of attention in related research.Figure 4.",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "In the 1980s, Bissell and others pioneered the three-dimensional(3D) culturing technique in the process of studying breast cancer, elucidating the influence of the extracellular matrix on gene expression (\nFigure 5\n).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "In 2013, Drose and colleagues extracted tumors from patients using surgical methods, enzymatically treated tumor fragments with collagenase and hyaluronidase, and cultivated the first patient-derived breast cancer organoid (27) (\nFigure 5\n).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "In 2015, Zubeldia-Plazaola and team used 3D cell culture technology to establish primary mammary epithelial cell lines more effectively, discovering that slow digestion at low enzyme concentrations could significantly enhance the success rate of organoid culturing (28) (\nFigure 5\n).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "In 2016, Zhang et al. first placed breast cells from individual mice Lgr5+ in an intestinal organoid culture medium and added growth factors like epidermal growth factor(EGF), exogenous ligands Wnt-3A of the Wnt signaling pathway, and R-spondin (\nFigure 5\n).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "In 2018, Sachs and others published a paper in “Cell”, where they collected samples from over 150 breast cancer patients, successfully producing over 100 organoids (\nFigure 5\n).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "Comparison of other breast cancer research models with organoid technology\nThe bibliometric analysis (\nFigure 4\n) identified the recent high-citation keywords in breast cancer organoids: “3D culture”, “mouse model”, and “morphogenesis mouse”.",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Additionally, “catalytic domain”, “progesterone receptor”, “triple-negative breast cancer”, “specific llama-derived antibodies”, “signaling mediate”, and “mesenchymal stromal cell” (\nFigure 3\n) demonstrated the mechanistic applications of breast cancer-like organs.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Figure 6\n summarizes the current four most important areas of application for breast cancer organoids.",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "Figure 1\n depicts the total number of papers published each year, with an increasing trend from six articles in 2003 to 156 articles in 2021.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "The USA had the most extensive collaborations with other countries and regions, including Europe, China, and Japan (\nFigure 2\n).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The top nine keyword groups from the analysis were “breast cancer organoid”, “therapeutic response”, “catalytic domain”, “progesterone receptor”, “triple-negative breast cancer”, “specific llama-derived antibodies”, “signaling mediate”, and “mesenchymal stromal cell” (\nFigure 3\n).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Figure 4\n demonstrates that researchers recently focused on “survival” (2022–2024), “3D culture” (2018–2022), “mouse model” (2019–2018), “stem cells” (2016–2020), and “morphogenesis” (2014–2020).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Each cluster can to a certain extent reflect a focal area of interest within the field, and be ranked based on the level of attention in related research.Figure 4.",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "In the 1980s, Bissell and others pioneered the three-dimensional(3D) culturing technique in the process of studying breast cancer, elucidating the influence of the extracellular matrix on gene expression (\nFigure 5\n).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "In 2013, Drose and colleagues extracted tumors from patients using surgical methods, enzymatically treated tumor fragments with collagenase and hyaluronidase, and cultivated the first patient-derived breast cancer organoid (27) (\nFigure 5\n).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "In 2015, Zubeldia-Plazaola and team used 3D cell culture technology to establish primary mammary epithelial cell lines more effectively, discovering that slow digestion at low enzyme concentrations could significantly enhance the success rate of organoid culturing (28) (\nFigure 5\n).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "In 2016, Zhang et al. first placed breast cells from individual mice Lgr5+ in an intestinal organoid culture medium and added growth factors like epidermal growth factor(EGF), exogenous ligands Wnt-3A of the Wnt signaling pathway, and R-spondin (\nFigure 5\n).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "In 2018, Sachs and others published a paper in “Cell”, where they collected samples from over 150 breast cancer patients, successfully producing over 100 organoids (\nFigure 5\n).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "Comparison of other breast cancer research models with organoid technology\nThe bibliometric analysis (\nFigure 4\n) identified the recent high-citation keywords in breast cancer organoids: “3D culture”, “mouse model”, and “morphogenesis mouse”.",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Additionally, “catalytic domain”, “progesterone receptor”, “triple-negative breast cancer”, “specific llama-derived antibodies”, “signaling mediate”, and “mesenchymal stromal cell” (\nFigure 3\n) demonstrated the mechanistic applications of breast cancer-like organs.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Figure 6\n summarizes the current four most important areas of application for breast cancer organoids.",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "Figure 1\n depicts the total number of papers published each year, with an increasing trend from six articles in 2003 to 156 articles in 2021.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "The USA had the most extensive collaborations with other countries and regions, including Europe, China, and Japan (\nFigure 2\n).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The top nine keyword groups from the analysis were “breast cancer organoid”, “therapeutic response”, “catalytic domain”, “progesterone receptor”, “triple-negative breast cancer”, “specific llama-derived antibodies”, “signaling mediate”, and “mesenchymal stromal cell” (\nFigure 3\n).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Figure 4\n demonstrates that researchers recently focused on “survival” (2022–2024), “3D culture” (2018–2022), “mouse model” (2019–2018), “stem cells” (2016–2020), and “morphogenesis” (2014–2020).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Each cluster can to a certain extent reflect a focal area of interest within the field, and be ranked based on the level of attention in related research.Figure 4.",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "In the 1980s, Bissell and others pioneered the three-dimensional(3D) culturing technique in the process of studying breast cancer, elucidating the influence of the extracellular matrix on gene expression (\nFigure 5\n).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "In 2013, Drose and colleagues extracted tumors from patients using surgical methods, enzymatically treated tumor fragments with collagenase and hyaluronidase, and cultivated the first patient-derived breast cancer organoid (27) (\nFigure 5\n).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "In 2015, Zubeldia-Plazaola and team used 3D cell culture technology to establish primary mammary epithelial cell lines more effectively, discovering that slow digestion at low enzyme concentrations could significantly enhance the success rate of organoid culturing (28) (\nFigure 5\n).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "In 2016, Zhang et al. first placed breast cells from individual mice Lgr5+ in an intestinal organoid culture medium and added growth factors like epidermal growth factor(EGF), exogenous ligands Wnt-3A of the Wnt signaling pathway, and R-spondin (\nFigure 5\n).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "In 2018, Sachs and others published a paper in “Cell”, where they collected samples from over 150 breast cancer patients, successfully producing over 100 organoids (\nFigure 5\n).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "Comparison of other breast cancer research models with organoid technology\nThe bibliometric analysis (\nFigure 4\n) identified the recent high-citation keywords in breast cancer organoids: “3D culture”, “mouse model”, and “morphogenesis mouse”.",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Additionally, “catalytic domain”, “progesterone receptor”, “triple-negative breast cancer”, “specific llama-derived antibodies”, “signaling mediate”, and “mesenchymal stromal cell” (\nFigure 3\n) demonstrated the mechanistic applications of breast cancer-like organs.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Figure 6\n summarizes the current four most important areas of application for breast cancer organoids.",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "Figure 1\n depicts the total number of papers published each year, with an increasing trend from six articles in 2003 to 156 articles in 2021.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "The USA had the most extensive collaborations with other countries and regions, including Europe, China, and Japan (\nFigure 2\n).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The top nine keyword groups from the analysis were “breast cancer organoid”, “therapeutic response”, “catalytic domain”, “progesterone receptor”, “triple-negative breast cancer”, “specific llama-derived antibodies”, “signaling mediate”, and “mesenchymal stromal cell” (\nFigure 3\n).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Figure 4\n demonstrates that researchers recently focused on “survival” (2022–2024), “3D culture” (2018–2022), “mouse model” (2019–2018), “stem cells” (2016–2020), and “morphogenesis” (2014–2020).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Each cluster can to a certain extent reflect a focal area of interest within the field, and be ranked based on the level of attention in related research.Figure 4.",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "In the 1980s, Bissell and others pioneered the three-dimensional(3D) culturing technique in the process of studying breast cancer, elucidating the influence of the extracellular matrix on gene expression (\nFigure 5\n).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "In 2013, Drose and colleagues extracted tumors from patients using surgical methods, enzymatically treated tumor fragments with collagenase and hyaluronidase, and cultivated the first patient-derived breast cancer organoid (27) (\nFigure 5\n).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "In 2015, Zubeldia-Plazaola and team used 3D cell culture technology to establish primary mammary epithelial cell lines more effectively, discovering that slow digestion at low enzyme concentrations could significantly enhance the success rate of organoid culturing (28) (\nFigure 5\n).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "In 2016, Zhang et al. first placed breast cells from individual mice Lgr5+ in an intestinal organoid culture medium and added growth factors like epidermal growth factor(EGF), exogenous ligands Wnt-3A of the Wnt signaling pathway, and R-spondin (\nFigure 5\n).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "In 2018, Sachs and others published a paper in “Cell”, where they collected samples from over 150 breast cancer patients, successfully producing over 100 organoids (\nFigure 5\n).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "Comparison of other breast cancer research models with organoid technology\nThe bibliometric analysis (\nFigure 4\n) identified the recent high-citation keywords in breast cancer organoids: “3D culture”, “mouse model”, and “morphogenesis mouse”.",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Additionally, “catalytic domain”, “progesterone receptor”, “triple-negative breast cancer”, “specific llama-derived antibodies”, “signaling mediate”, and “mesenchymal stromal cell” (\nFigure 3\n) demonstrated the mechanistic applications of breast cancer-like organs.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Figure 6\n summarizes the current four most important areas of application for breast cancer organoids.",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "Figure 1\n depicts the total number of papers published each year, with an increasing trend from six articles in 2003 to 156 articles in 2021.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "The USA had the most extensive collaborations with other countries and regions, including Europe, China, and Japan (\nFigure 2\n).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The top nine keyword groups from the analysis were “breast cancer organoid”, “therapeutic response”, “catalytic domain”, “progesterone receptor”, “triple-negative breast cancer”, “specific llama-derived antibodies”, “signaling mediate”, and “mesenchymal stromal cell” (\nFigure 3\n).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Figure 4\n demonstrates that researchers recently focused on “survival” (2022–2024), “3D culture” (2018–2022), “mouse model” (2019–2018), “stem cells” (2016–2020), and “morphogenesis” (2014–2020).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Each cluster can to a certain extent reflect a focal area of interest within the field, and be ranked based on the level of attention in related research.Figure 4.",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Figure 1\n depicts the total number of papers published each year, with an increasing trend from six articles in 2003 to 156 articles in 2021.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "The USA had the most extensive collaborations with other countries and regions, including Europe, China, and Japan (\nFigure 2\n).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Figure 1\n depicts the total number of papers published each year, with an increasing trend from six articles in 2003 to 156 articles in 2021.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Figure 1\n depicts the total number of papers published each year, with an increasing trend from six articles in 2003 to 156 articles in 2021.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "The USA had the most extensive collaborations with other countries and regions, including Europe, China, and Japan (\nFigure 2\n).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The USA had the most extensive collaborations with other countries and regions, including Europe, China, and Japan (\nFigure 2\n).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The top nine keyword groups from the analysis were “breast cancer organoid”, “therapeutic response”, “catalytic domain”, “progesterone receptor”, “triple-negative breast cancer”, “specific llama-derived antibodies”, “signaling mediate”, and “mesenchymal stromal cell” (\nFigure 3\n).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Figure 4\n demonstrates that researchers recently focused on “survival” (2022–2024), “3D culture” (2018–2022), “mouse model” (2019–2018), “stem cells” (2016–2020), and “morphogenesis” (2014–2020).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Each cluster can to a certain extent reflect a focal area of interest within the field, and be ranked based on the level of attention in related research.Figure 4.",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "The top nine keyword groups from the analysis were “breast cancer organoid”, “therapeutic response”, “catalytic domain”, “progesterone receptor”, “triple-negative breast cancer”, “specific llama-derived antibodies”, “signaling mediate”, and “mesenchymal stromal cell” (\nFigure 3\n).",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Figure 4\n demonstrates that researchers recently focused on “survival” (2022–2024), “3D culture” (2018–2022), “mouse model” (2019–2018), “stem cells” (2016–2020), and “morphogenesis” (2014–2020).",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "In the 1980s, Bissell and others pioneered the three-dimensional(3D) culturing technique in the process of studying breast cancer, elucidating the influence of the extracellular matrix on gene expression (\nFigure 5\n).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "In 2013, Drose and colleagues extracted tumors from patients using surgical methods, enzymatically treated tumor fragments with collagenase and hyaluronidase, and cultivated the first patient-derived breast cancer organoid (27) (\nFigure 5\n).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "In 2015, Zubeldia-Plazaola and team used 3D cell culture technology to establish primary mammary epithelial cell lines more effectively, discovering that slow digestion at low enzyme concentrations could significantly enhance the success rate of organoid culturing (28) (\nFigure 5\n).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "In 2016, Zhang et al. first placed breast cells from individual mice Lgr5+ in an intestinal organoid culture medium and added growth factors like epidermal growth factor(EGF), exogenous ligands Wnt-3A of the Wnt signaling pathway, and R-spondin (\nFigure 5\n).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "In 2018, Sachs and others published a paper in “Cell”, where they collected samples from over 150 breast cancer patients, successfully producing over 100 organoids (\nFigure 5\n).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "In the 1980s, Bissell and others pioneered the three-dimensional(3D) culturing technique in the process of studying breast cancer, elucidating the influence of the extracellular matrix on gene expression (\nFigure 5\n).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "In 2013, Drose and colleagues extracted tumors from patients using surgical methods, enzymatically treated tumor fragments with collagenase and hyaluronidase, and cultivated the first patient-derived breast cancer organoid (27) (\nFigure 5\n).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "In 2015, Zubeldia-Plazaola and team used 3D cell culture technology to establish primary mammary epithelial cell lines more effectively, discovering that slow digestion at low enzyme concentrations could significantly enhance the success rate of organoid culturing (28) (\nFigure 5\n).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "In 2016, Zhang et al. first placed breast cells from individual mice Lgr5+ in an intestinal organoid culture medium and added growth factors like epidermal growth factor(EGF), exogenous ligands Wnt-3A of the Wnt signaling pathway, and R-spondin (\nFigure 5\n).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "In 2018, Sachs and others published a paper in “Cell”, where they collected samples from over 150 breast cancer patients, successfully producing over 100 organoids (\nFigure 5\n).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "In the 1980s, Bissell and others pioneered the three-dimensional(3D) culturing technique in the process of studying breast cancer, elucidating the influence of the extracellular matrix on gene expression (\nFigure 5\n).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "In 2013, Drose and colleagues extracted tumors from patients using surgical methods, enzymatically treated tumor fragments with collagenase and hyaluronidase, and cultivated the first patient-derived breast cancer organoid (27) (\nFigure 5\n).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "In 2015, Zubeldia-Plazaola and team used 3D cell culture technology to establish primary mammary epithelial cell lines more effectively, discovering that slow digestion at low enzyme concentrations could significantly enhance the success rate of organoid culturing (28) (\nFigure 5\n).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "In 2016, Zhang et al. first placed breast cells from individual mice Lgr5+ in an intestinal organoid culture medium and added growth factors like epidermal growth factor(EGF), exogenous ligands Wnt-3A of the Wnt signaling pathway, and R-spondin (\nFigure 5\n).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "In 2018, Sachs and others published a paper in “Cell”, where they collected samples from over 150 breast cancer patients, successfully producing over 100 organoids (\nFigure 5\n).",
      "figure_references": [
        {
          "figure_number": "Figure 5",
          "panel": "",
          "figure_key": "figure_5"
        }
      ]
    },
    {
      "sentence": "Comparison of other breast cancer research models with organoid technology\nThe bibliometric analysis (\nFigure 4\n) identified the recent high-citation keywords in breast cancer organoids: “3D culture”, “mouse model”, and “morphogenesis mouse”.",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "The bibliometric analysis (\nFigure 4\n) identified the recent high-citation keywords in breast cancer organoids: “3D culture”, “mouse model”, and “morphogenesis mouse”.",
      "figure_references": [
        {
          "figure_number": "Figure 4",
          "panel": "",
          "figure_key": "figure_4"
        }
      ]
    },
    {
      "sentence": "Additionally, “catalytic domain”, “progesterone receptor”, “triple-negative breast cancer”, “specific llama-derived antibodies”, “signaling mediate”, and “mesenchymal stromal cell” (\nFigure 3\n) demonstrated the mechanistic applications of breast cancer-like organs.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Figure 6\n summarizes the current four most important areas of application for breast cancer organoids.",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        }
      ]
    },
    {
      "sentence": "Additionally, “catalytic domain”, “progesterone receptor”, “triple-negative breast cancer”, “specific llama-derived antibodies”, “signaling mediate”, and “mesenchymal stromal cell” (\nFigure 3\n) demonstrated the mechanistic applications of breast cancer-like organs.",
      "figure_references": [
        {
          "figure_number": "Figure 3",
          "panel": "",
          "figure_key": "figure_3"
        }
      ]
    },
    {
      "sentence": "Figure 6\n summarizes the current four most important areas of application for breast cancer organoids.",
      "figure_references": [
        {
          "figure_number": "Figure 6",
          "panel": "",
          "figure_key": "figure_6"
        }
      ]
    }
  ],
  "extraction_stats": {
    "figures_count": 6,
    "claims_count": 141,
    "images_downloaded": 6,
    "tables_filtered": 6
  }
}